An inherent acceleratory effect of insulin on small intestinal transit and its pharmacological characterization in normal mice

World Journal of Gastroenterology

Volumn 12, Issue 16, 2006, Pages 2593-2600

  Reddy, Peddyreddy R Murali Krishna ^a   Dkhar, Steven Aibor ^a   Ramaswamy, Subramanian ^b   Naveen, Amrithraj Theophilus ^a   Shewade, Deepak Gopal ^c  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b Aarupadai Veedu Medical College and Hospital   (India)

^c Department of Pharmacy   (Uganda)

Author keywords

Adrenergic system; Blood glucose levels; Ca2+ channels; Cholinergic system; Instestinal transit; Insulin; Opioid system; Serotonergic system

Indexed keywords

ATROPINE; CALCIUM CHANNEL; CHARCOAL; CLONIDINE; GLIBENCLAMIDE; GLUCOSE; INSULIN; NALOXONE; ONDANSETRON; OPIATE RECEPTOR; VERAPAMIL;

ACCELERATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; INHIBITION KINETICS; INSULIN RELEASE; INTESTINE TRANSIT TIME; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33646460275     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i16.2593     Document Type: Article

References (51)

1. Davis SN. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc 2006:1613-1645
2. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000; 24: 855-872
3. Rajendran NN, Thirugnanasambandam P, Parvathavarthini S, Viswanathan S, Ramaswamy S. Modulation by insulin rather than blood glucose of the pain threshold in acute physiological and flavone induced antinociception in mice. Indian J Exp Biol 2001; 39: 1009-1016
4. Takeshita N, Yamaguchi I. Insulin attenuates formalin-induced nociceptive response in mice through a mechanism that is deranged by diabetes mellitus. J Pharmacol Exp Ther 1997; 281: 315-321
5. Powers AC. Diabetes mellitus. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrisons principles of internal medicine 16th ed. New York: McGraw Hill Companies, Inc 2005: 2152-2180
6. Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep 2003; 3: 43-48
7. Perusicova J. Gastrointestinal complications in diabetes mellitus. Vnitr Lek 2004; 50: 338-343
8. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med 2001; 161: 1989-1996
9. el-Salhy M. The possible role of the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol 2002; 17: 1153-1161
10. Schvarcz E, Palmer M, Aman J, Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care 1995; 18: 674-676
11. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002; 97: 604-611
12. Ghaffari K, Savadkuhi ST, Honar H, Riazi K, Shafaroodi H, Moezi L, Ebrahimkhani MR, Tahmasebi MS, Dehpour AR. Obstructive cholestasis alters intestinal transit in mice: role of opioid system. Life Sci 2004; 76: 397-406
13. Wang H, Tan C, Bai X, Du Y, Lin B. Pharmacological studies of anti-diarrhoeal activity of Gentianopsis paludosa. J Ethnopharmacol 2006; 105: 114-117
14. Sacks DM. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz; text book of clinical chemistry and molecular diagnostics. 4th ed. Missouri: Saunders, 2006: 837-901
15. Chaudhuri L, Basu S, Seth P, Chaudhuri T, Besra SE, Vedasiromoni JR, Ganguly DK. Prokinetic effect of black tea on gastrointestinal motility. Life Sci 2000; 66: 847-854
16. Donoso MV, Carvajal A, Paredes A, Tomic A, Koenig CS, Huidobro-Toro JP. alpha2-Adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals. Peptides 2002; 23: 1663-1671
17. DiTullio NW, Cieslinski L, Matthews WD, Storer B. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 1984; 228: 168-173
18. Nagakura Y, Naitoh Y, Kamato T, Yamano M, Miyata K. Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur J Pharmacol 1996; 311: 67-72
19. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989;248: 1269-1275
20. Peana AT, De Montis MG, Nieddu E, Spano MT, D'Aquila PS, Pippia P. Profile of spinal and supra-spinal antinociception of (-)-linalool. Eur J Pharmacol 2004; 485: 165-174
21. Ramaswamy S, Rajasekaran M, Bapna JS. Role of calcium in prolactin analgesia. Arch Int Pharmacodyn Ther 1986; 283: 56-60
22. Amos S, Binda L, Kunle OF, Okafor I, Emeje M, Akah PA, Wambebe C, Gamaniel K. Smooth muscle contraction induced by Indigofera dendroides leaf extracts may involve calcium mobilization via potential sensitive channels. Phytother Res 2003; 17: 792-796
23. Ramaswamy S, Reddy PRMK, Shewade DG. Clonidine induced antinociception: biochemical and cellular evidences on the mechanism of action. Indian J Pharmacol 1998; 30: 30-33
24. Ojewole JA, Drewes SE, Khan F. Vasodilatory and hypoglycaemic effects of two pyrano-isoflavone extractives from Eriosema kraussianum N. E. Br. [Fabaceae] rootstock in experimental rat models. Phytochemistry 2006; 67: 610-617
25. Belai A, Milner P, Aberdeen J, Burnstock G. Selective damage to sensorimotor perivascular nerves in the mesenteric vessels of diabetic rats. Diabetes 1996; 45: 139-143
26. Fahim MA, el-Sabban F, Davidson N. Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice. Anat Rec 1998; 251: 240-244
27. Miyamoto Y, Yoneda M, Morikawa A, Itoh H, Makino I. Gastric neuropeptides and gastric motor abnormality in streptozotocin-induced diabetic rats: observation for four weeks after streptozotocin. Dig Dis Sci 2001; 46: 1596-1603
28. Chang FY, Doong ML, Chen TS, Lee SD, Wang PS. Altered intestinal transit is independent of gastroparesis in the early diabetic rats. Chin J Physiol 1997; 40: 31-35
29. Russo A, Stevens JE, Chen R, Gentilcore D, Burnet R, Horowitz M, Jones KL. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90: 4489-4495
30. Hjelland IE, Oveland NP, Leversen K, Berstad A, Hausken T. Insulin-induced hypoglycemia stimulates gastric vagal activity and motor function without increasing cardiac vagal activity. Digestion 2005; 72: 43-48
31. Kamm MA. Why the enteric nervous system is important to clinicians. Gut 2000; 47 Sup.pl 4: iv8- iv9; discussion iv10
32. Ghosh MN. Quantitative study of agonists on isolated preparations. In: Ghosh MN, ed. Fundamentals of experimental pharmacology. 3rd ed. Kolkata: Hilton and Company, 2005: 121-133
33. Ghosh MN. Quantitative study of antagonists on isolated preparations. In: Ghosh MN, ed. Fundamentals of experimental pharmacology. 3rd ed. Kolkata: Hilton & Company, 2005: 134-147
34. Ghosh MN. Identification and estimation of biologically active substances. In: Ghosh MN, ed. Fundamentals of experimental pharmacology. 3rd ed. Kolkata: Hilton & Company, 2005: 148-159
35. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc 2006: 183-200
36. Liu L, Coupar IM. Characterisation of pre- and postsynaptic alpha-adrenoceptors in modulation of the rat ileum longitudinal and circular muscle activities. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 248-256
37. Chung S, Kwon S, Kim Y, Ahn D, Lee Y, Nam T. Inhibition by clonidine of the carbachol-induced tension development and nonselective cationic current in guinea pig ileal myocytes. Jpn J Pharmacol 2001; 87: 125-133
38. Elangbam CS, Lightfoot RM, Yoon LW, Creech DR, Geske RS, Crumbley CW, Gates LD, Wall HG. 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats. J Histochem Cytochem 2005; 53: 671-677
39. Kiso T, Ito H, Miyata K, Kamato T, Naitoh Y, Iwaoka K, Yamaguchi T. A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain. Eur J Pharmacol 2001; 431: 35-41
40. Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an antiemetic in children. Paediatr Drugs 2001; 3: 441-479
41. Bosnjak SM, Neskovic-Konstantinovic ZB, Radulovic SS, Susnjar S, Mitrovi LB. High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer. J Chemother 2000; 12: 446-453
42. Sternini C, Patierno S, Selmer IS, Kirchgessner A. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil 2004; 16 Suppl 2: 3-16
43. Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett 2004; 361: 192-195
44. Gutstein HB, Akil H. Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed, New York: McGraw-Hill Companies, Inc 2006: 547-590
45. Pasricha PJ. Treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc 2006: 983-1008
46. Champion MC, Sullivan SN, Chamberlain M, Vezina W. Naloxone and morphine inhibit gastric emptying of solids. Can J Physiol Pharmacol 1982; 60: 732-734
47. Asai T, Power I. Naloxone inhibits gastric emptying in the rat. Anesth Analg 1999; 88: 204-208
48. Ganong WF. Excitable tissue: Muscle. In: Ganong WF ed. Review of medical physiology. 22nd ed. Boston: McGraw Hill, 2005: 65-84
49. Horowitz B, Ward SM, Sanders KM. Cellular and molecular basis for electrical rhythmicity in gastrointestinal muscles. Annu Rev Physiol 1999; 61: 19-43
50. Sanders KM. Postjunctional electrical mechanisms of enteric neurotransmission. Gut 2000; 47 Suppl 4: iv23-iv25; discussion iv26
51. Michel T. Treatment of myocardial ischemia. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc 2006: 823-844